assistenza infermieristica ad un paziente sottoposto a rivascolarizzazione miocardica mediante doppio bypass coronarico - Nursing Case Study

Pathophysiology

• Primary mechanism: Ischemia relief by bypass grafts - The double bypass surgery creates new pathways for blood to reach the heart muscle, circumventing blocked or narrowed coronary arteries, thereby restoring oxygen-rich blood flow and reducing ischemic damage to myocardial tissues.

• Secondary mechanism: Inflammatory response - Post-surgery, an inflammatory response is triggered as the body reacts to the surgical trauma and implanted grafts. This can lead to localized swelling, increased cardiac workload, and the potential for complications such as pericarditis or graft occlusion if not appropriately managed.

• Key complication: Graft patency and healing - Ensuring the longevity and functionality of the grafts is crucial. Early complications like thrombosis or late complications such as graft stenosis can impair graft patency, necessitating vigilant monitoring for signs of compromised circulation, such as changes in ECG or chest pain, to prevent myocardial infarction.

Patient Profile

Demographics:

70 years old, male, retired construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes Mellitus, Hyperlipidemia, Previous Myocardial Infarction

• Current medications: Metoprolol, Lisinopril, Atorvastatin, Metformin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Chest discomfort and shortness of breath post-surgery

• Key symptoms: Mild chest pain, dyspnea, fatigue, mild swelling in lower extremities

• Vital signs: Blood pressure 145/90 mmHg, Heart rate 105 bpm, Respiratory rate 22 breaths per minute, Temperature 37.8°C, Oxygen saturation 92% on room air

Section 1

Following the initial post-operative period, the patient was closely monitored for any changes in clinical status. On the third post-operative day, the patient began experiencing increased chest discomfort and exhibited signs of respiratory distress. A detailed assessment was undertaken, revealing a slight increase in bilateral lower extremity edema and jugular venous distention. Auscultation of the heart revealed a pericardial friction rub, suggestive of pericarditis, a potential complication following cardiac surgery.

Vital signs indicated a persistent tachycardia with a heart rate of 110 bpm, and blood pressure was notably elevated at 150/95 mmHg. Respiratory rate remained elevated at 24 breaths per minute, and oxygen saturation further declined to 90% on room air. Laboratory tests showed elevated white blood cell count at 14,000/mm³ and a C-reactive protein level of 45 mg/L, indicating an ongoing inflammatory process. An ECG revealed new ST-segment elevation, raising concerns for possible graft occlusion or myocardial injury.

In response to these findings, the care team initiated a comprehensive management plan to address the pericarditis and potential for further cardiac complications. The patient was started on non-steroidal anti-inflammatory drugs (NSAIDs) to reduce inflammation and alleviate chest pain. Continuous cardiac monitoring was implemented to detect any arrhythmic events, and supplemental oxygen was provided to maintain adequate oxygenation. An echocardiogram was ordered to assess for pericardial effusion and evaluate graft patency, while anticoagulation therapy was reviewed to prevent thrombotic events. These interventions aimed to stabilize the patient's condition and prevent progression to more severe cardiac complications.

Section 2

As the care team continued to monitor the patient, they observed that, despite the introduction of NSAIDs and supplemental oxygen, the patient's chest discomfort and respiratory distress persisted. On the fourth post-operative day, a repeat echocardiogram revealed a small pericardial effusion, but graft patency appeared maintained. However, the patient’s oxygen saturation remained at 90% despite increased oxygen delivery, and auscultation of the lungs indicated diminished breath sounds at the bases, raising suspicion for possible atelectasis or pleural effusion, both of which can occur post-operatively and complicate recovery.

Simultaneously, laboratory tests showed a further rise in C-reactive protein to 60 mg/L, suggesting an escalating inflammatory response. Given the persistence of tachycardia and the elevated blood pressure, the team adjusted the patient's medication regimen, introducing a beta-blocker to manage these symptoms and reduce myocardial oxygen demand. Additionally, diuretics were considered to address the bilateral lower extremity edema and potential fluid overload contributing to the respiratory symptoms.

These adjustments aimed to mitigate the patient's symptoms and prevent further decompensation. The clinical team was vigilant for signs of worsening heart failure or significant pericardial effusion that might necessitate more aggressive interventions, such as pericardiocentesis. The unfolding scenario required close observation and ongoing assessment to ensure timely identification of any new complications, as well as re-evaluation of the therapeutic approach to optimize the patient's recovery trajectory.

Section 3

As the clinical team continued to manage the patient's post-operative course, they were alerted to a change in the patient's status on the fifth day after surgery. The patient reported increased fatigue and was noted to have a more pronounced shortness of breath at rest. Vital signs revealed a heart rate of 110 beats per minute, blood pressure of 150/90 mmHg, and a respiratory rate of 24 breaths per minute. Despite supplemental oxygen, the patient's oxygen saturation dropped to 88%. The skin appeared cool and clammy, and there was an observable increase in jugular venous distention.

A repeat chest X-ray was ordered promptly, revealing a moderate right-sided pleural effusion and atelectasis in the right lower lobe, which were likely contributing to the patient's respiratory compromise. The lab results showed a further rise in C-reactive protein to 75 mg/L, indicating a persistent inflammatory process. Serum electrolytes revealed hyponatremia, with sodium levels at 130 mEq/L, suggesting a possible dilutional effect due to fluid overload.

In response to these findings, the care team intensified their interventions. Diuretics were administered to reduce fluid overload and manage pleural effusion. An incentive spirometry regimen was initiated to encourage lung expansion and improve atelectasis. The patient was also placed on a higher level of oxygen support to maintain adequate saturation. The team continued to monitor the patient closely, assessing for any further deterioration that might necessitate more invasive procedures, such as thoracentesis for the pleural effusion or adjustment of diuretic therapy to optimize fluid balance. These measures were aimed at stabilizing the patient's condition and preventing the development of more severe complications, while also providing an opportunity for further clinical evaluation and adjustment of the treatment plan.

Section 4

As the care team monitored the patient's response to the intensified interventions, a noticeable change in the patient's status emerged on the seventh day post-surgery. Despite initial improvements with diuretic therapy and oxygen support, the patient began experiencing new symptoms. The patient reported a persistent cough and increased difficulty breathing, even while using the incentive spirometer. Vital signs were concerning: the heart rate had risen further to 120 beats per minute, blood pressure was elevated at 160/95 mmHg, and the respiratory rate had increased to 28 breaths per minute. Oxygen saturation remained low at 86% despite high-flow oxygen, indicating a potential worsening of respiratory function.

A follow-up chest X-ray was performed, revealing that the right-sided pleural effusion had slightly increased, and there was evidence of bilateral infiltrates, suggesting the development of pulmonary edema. This finding was corroborated by laboratory results showing a decrease in arterial blood gas measurements with a pH of 7.32, indicating respiratory acidosis, and PaO2 of 55 mmHg. Electrolytes were further imbalanced, with sodium levels dropping to 128 mEq/L and potassium levels at 3.0 mEq/L, raising concerns for potential cardiac arrhythmias due to hypokalemia.

In response to these complications, the clinical team adjusted the treatment strategy. They increased the dosage of diuretics to aggressively manage the fluid overload while carefully monitoring electrolyte levels to prevent further imbalances. The patient was also placed on non-invasive positive pressure ventilation (NIPPV) to support respiratory function and improve oxygenation. The team considered the possibility of performing thoracentesis to address the pleural effusion if the patient's condition did not stabilize. These steps were crucial in addressing the acute respiratory distress and preventing progression to more severe complications, such as acute respiratory failure, while allowing the team to reassess the patient's overall fluid management and electrolyte replacement protocol.

Section 5

Despite the intensified interventions, the patient's condition continued to evolve, presenting new challenges for the care team. On the ninth day post-surgery, the patient's respiratory status remained precarious. Although the use of non-invasive positive pressure ventilation provided some relief, arterial blood gas analysis revealed persistent respiratory acidosis with a slight improvement in pH to 7.34 but still inadequate PaO2 at 58 mmHg. The patient continued to exhibit tachypnea with a respiratory rate of 30 breaths per minute, and oxygen saturation remained suboptimal at 88% despite NIPPV support. These signs pointed toward a persistent issue with ventilation-perfusion mismatch, possibly aggravated by the unresolved pleural effusion and ongoing pulmonary edema.

Simultaneously, the patient's electrolyte imbalances persisted despite careful monitoring and replacement efforts. Sodium levels continued to hover around 130 mEq/L, and potassium levels showed only marginal improvement, reaching 3.2 mEq/L. This raised ongoing concerns about the potential for cardiac instability. The patient's heart rate remained elevated at 115 beats per minute, and occasional premature ventricular contractions were noted on telemetry, reinforcing the need for vigilant cardiac monitoring. The clinical team debated the necessity of a more invasive approach, such as thoracentesis, to ameliorate the pleural effusion and possibly enhance the patient's respiratory function.

The unfolding scenario required the team to critically reassess their treatment plan. They had to balance the need for aggressive diuresis with the risk of further electrolyte disturbances and monitor for signs of cardiac arrhythmias. Additionally, the possibility of initiating low-dose inotropic support to address potential cardiac decompensation was considered. The team also explored the utilization of adjunct therapies, such as bronchodilators or nebulized medications, to optimize pulmonary function. These considerations underscored the complexity of managing the patient's care and highlighted the importance of integrating clinical data with ongoing assessments to guide decision-making and improve patient outcomes.